Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injecti... Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.95 | 2.28915662651 | 41.5 | 45.06 | 40.735 | 825875 | 42.44298867 | CS |
4 | -6.61 | -13.4732980024 | 49.06 | 51.27 | 40.735 | 516512 | 45.01326852 | CS |
12 | 0.79 | 1.89630340855 | 41.66 | 51.61 | 37.46 | 741194 | 44.43771551 | CS |
26 | 7.29 | 20.7337883959 | 35.16 | 51.61 | 32.65 | 626887 | 41.79104602 | CS |
52 | 26.36 | 163.828464885 | 16.09 | 51.61 | 14.2 | 859291 | 38.68240274 | CS |
156 | 19.49 | 84.8867595819 | 22.96 | 51.61 | 5.2 | 532242 | 26.55584154 | CS |
260 | 31.04 | 272.042068361 | 11.41 | 51.61 | 5.2 | 451874 | 26.40720727 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.